For in vitro diagnostic use.
As cancer incidence continues to rise worldwide, healthcare providers need diagnostic solutions that deliver greater confidence and precision. Abbott's oncology portfolio is designed to support clinicians and laboratories with reliable biomarker testing that helps guide clinical decisions across the cancer care continuum.
With one out of every two people expected to get cancer during their lifetime there is a clear need to optimize diagnostic solutions to tackle key challenges in oncology management.1
Modern oncology increasingly utilizes advanced testing approaches that integrate multiple biomarkers into a single result using sophisticated algorithms. Known as Multianalyte Assays with Algorithmic Analysis (MAAAs), these tests may enhance overall clinical performance and provide more comprehensive insights than individual biomarkers alone.
Abbott offers a wide variety of assays to assist in the risk-stratification, diagnosis and management for many types of cancers including, colon, liver, ovarian, breast, pancreatic, testicular, gastrointestinal, lung and prostate cancer.
The oncology solutions from Abbott can help you reduce laboratory operational costs while maintaining the quality standards necessary to have a meaningful positive impact to the quality and cost of health care.
| Cancer |
| AFP |
| CA 125 II |
| CA 15-3 |
| CA 19-9 (CA 19-9 XR) |
| CA 72-4* |
| CEA |
| CYFRA 21-1 |
| HE-4 (ROMA) |
| Immunoglobulin A (IgA) |
| Immunoglobulin E (IgE) |
| Immunoglobulin G (IgG) |
| Immunoglobulin M (IgM) |
| Human Kappa (κ) FreeLight Chain |
| Human Lambda (λ) Free Light Chain |
| NSE |
| Pepsinogen I |
| Pepsinogen II |
| PIVKA-II |
| ProGRP |
| PSA, Free |
| PSA, Total |
| SCC |
*In development. Not commercially available.
Login or register for a new account on the Lab Central customer portal. Here you can view assay specific package inserts for intended use, important safety information and manage your personalized lab metrics.
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
Abbott's high-quality immunoassay menu helps laboratories meet requirements to be reliable, accurate and precise.
Learn how Abbott has helped physicians evaluate suspected mild traumatic brain injury (mTBI).
Discover how Alinity uses powerful technology to help redefine and improve operational productivity and confidence in your laboratory.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
